Table 1 Targeting efficacy of conventional Au-based NPs by inductively coupled plasma mass spectrometer (ICP-MS)

ELP-Au NPs

180 μg Au mL⁻¹

0.15–0.18 μg mm⁻³

> 90 (after 1 day from injection)

34 (after 30 days from injection)

Intratumoral

[58]

GNPs

186 μg Au mL⁻¹

~ 0.186 μg mm⁻³

~ 100 (right after injection) (this value was calculated from concentration of Au in tumor)

Intratumoral

[43]

sAuNR-laden-macrophages

2.1 μg Au μL⁻¹

~ 0.525 μg mm⁻³

~ 100 (right after injection) (this value was calculated from concentration of Au in tumor)

Intratumoral

[47]

Bare AuNSs

3 mg mL⁻¹

0.07245 μg mm⁻³

1.61 (after 48 h from injection)

Intravenous

[52]

MPCM-AuNSs

ND.

ND

7.48 (after 48 h from injection)

Intravenous

[52]

CPGA^a

10.4 mg Au kg⁻¹ (ND. of administrated volume)

~ 0.0147 μg mm⁻³

7.06 ± 0.49 (after 24 h from injection)

Intravenous

[56]

Au NPs

2 mg mL⁻¹ (10 mg kg⁻¹)

~ 0.02 μg mm⁻³ (after 12 h from injection)

1 (after 2 h from injection)

6 (after 12 h from injection)

2 (after 24 h from injection)

Intravenous

[54]

AuNP@peptide

ND

ND

3 (after 2 h from injection)

9 (after 12 h from injection)

7 (after 24 h from injection)

Intravenous

[54]